Clearstead Advisors’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.2K | Hold |
1,515
| – | – | ﹤0.01% | 1782 |
|
2025
Q1 | $12.1K | Hold |
1,515
| – | – | ﹤0.01% | 1558 |
|
2024
Q4 | $13.8K | Sell |
1,515
-1,350
| -47% | -$12.3K | ﹤0.01% | 1493 |
|
2024
Q3 | $26.3K | Buy |
2,865
+800
| +39% | +$7.34K | ﹤0.01% | 1351 |
|
2024
Q2 | $20.2K | Hold |
2,065
| – | – | ﹤0.01% | 1376 |
|
2024
Q1 | $25.7K | Buy |
2,065
+1,425
| +223% | +$17.7K | ﹤0.01% | 899 |
|
2023
Q4 | $13.8K | Sell |
640
-60
| -9% | -$1.29K | ﹤0.01% | 1001 |
|
2023
Q3 | $13K | Buy |
700
+350
| +100% | +$6.51K | ﹤0.01% | 1081 |
|
2023
Q2 | $8.86K | Buy |
350
+200
| +133% | +$5.06K | ﹤0.01% | 999 |
|
2023
Q1 | $3.89K | Sell |
150
-180
| -55% | -$4.66K | ﹤0.01% | 1049 |
|
2022
Q4 | $7.8K | Buy |
330
+65
| +25% | +$1.54K | ﹤0.01% | 935 |
|
2022
Q3 | $7K | Sell |
265
-335
| -56% | -$8.85K | ﹤0.01% | 939 |
|
2022
Q2 | $20K | Buy |
600
+175
| +41% | +$5.83K | ﹤0.01% | 802 |
|
2022
Q1 | $31K | Buy |
425
+150
| +55% | +$10.9K | ﹤0.01% | 773 |
|
2021
Q4 | $25K | Sell |
275
-2,238
| -89% | -$203K | ﹤0.01% | 770 |
|
2021
Q3 | $319K | Buy |
2,513
+2,380
| +1,789% | +$302K | 0.02% | 302 |
|
2021
Q2 | $22K | Hold |
133
| – | – | ﹤0.01% | 695 |
|
2021
Q1 | $24K | Hold |
133
| – | – | ﹤0.01% | 644 |
|
2020
Q4 | $27K | Buy |
133
+3
| +2% | +$609 | ﹤0.01% | 588 |
|
2020
Q3 | $29K | Buy |
130
+5
| +4% | +$1.12K | ﹤0.01% | 547 |
|
2020
Q2 | $24K | Hold |
125
| – | – | ﹤0.01% | 513 |
|
2020
Q1 | $19K | Buy |
+125
| New | +$19K | ﹤0.01% | 509 |
|